San Francisco-based healthcare technology company Foundation Health announced that its PAIGE AI platform will be utilized to automate patient outreach and communication workflows in a six-month program at Intermountain Health's specialty pharmacy operations.
The PAIGE AI platform will automate SMS messaging and voice communications, such as patient assessment calls, refill reminders, benefits verification and medication onboarding.
The aim is to allow Intermountain's pharmacy team, which serves over 14,000 patients in Midvale, Utah, to concentrate on patient care and therapeutic guidance.
The companies also plan to explore new AI use cases in the future, such as voice-enabled tools and AI-enabled prior authorization automation, across Intermountain's wider healthcare operations.
Mason Hilton, system director of pharmacy operations at Intermountain Health, said that the partnership marks a crucial step in advancing pharmacy services for patients with complex conditions.
"By integrating Foundation Health’s innovative communication and outreach tools into our specialty pharmacy workflows, we’re proactively closing care gaps and improving timely access to critical therapies," Hilton said in a statement.
THE LARGER TREND
In June, Layer Health announced it would receive a strategic investment from Intermountain Health's investment arm, Intermountain Ventures, and Intermountain Health will become an innovation partner and early user of Layer Health's AI-powered chart review platform.
The two companies said that they were engaged in a multi-year venture to deploy Layer Health's AI platform across multiple clinical registries, aiming to improve the scalability of clinical data abstraction.
In January, Neuroflow, a behavioral health technology and analytics company, acquired Intermountain Health's proprietary health analytics model.
The acquisition aims to enhance NeuroFlow's analytics and AI proficiencies and allow for the broad deployment of assessment models. It also aims to provide more healthcare organizations with the behavioral health intelligence required to enhance clinical decision-making and health outcomes.
Moreover, the two organizations will continue to collaborate on the evolution of the risk complexity model, with NeuroFlow making these enhanced capabilities available to other clients in 2025.
In 2024, Foundation Health announced the closure of a $6 million seed funding round.
